Status:

COMPLETED

Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction

Lead Sponsor:

Stanford University

Collaborating Sponsors:

University of California, San Diego

Conditions:

Olfactory Disorder

Olfaction Disorders

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This randomized clinical trial will evaluate the benefit of platelet-rich plasma (PrP) in the treatment of olfactory dysfunction. PrP can be isolated from a patient's own blood and has been found in p...

Detailed Description

Olfactory dysfunction constitutes a common impairment in the general population, affecting nearly 20 million in the USA and severely impairing quality of life. Unfortunately, this problem is often per...

Eligibility Criteria

Inclusion

  • Patients \>= 18 years of age
  • Patients who have olfactory loss (based off of UPSIT score \<= 33 out of 40)
  • Patients who also have an age-adjusted TDI Sniffin' Sticks score that demonstrates hyposmia (TDI\>16 and \<30)
  • Etiology of olfactory loss is due to URI or idiopathic
  • At least 6 months of olfactory loss but less than 12 months
  • Patients can have been previously treated with oral and topical steroids but this is not a requirement
  • Patients will receive concurrent olfactory training - the practice of smelling strong odors (standard of care)
  • Be able to read and understand English
  • Agree to participate in the study
  • Be able and willing to provide Informed Consent

Exclusion

  • Patients \< 18 years of age
  • Pregnant females
  • Patient who have any structural abnormalities on nasal endoscopy or radiographic imaging
  • Olfactory loss due to trauma, chronic sinusitis / inflammation / polyps, neoplasms, or neurodegenerative diseases
  • Patients who have had olfactory loss \> 12 months
  • Patients with bleeding disorders or on blood thinners such as coumadin and plavix

Key Trial Info

Start Date :

June 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 11 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04406584

Start Date

June 22 2021

End Date

August 11 2022

Last Update

March 13 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of California - San Diego

San Diego, California, United States, 92093

2

Stanford University

Stanford, California, United States, 94305